Adherence of Pharmaceutical Advertisements to FDA Guidelines
Author Information
Author(s): Deborah Korenstein, Salomeh Keyhani, Ali Mendelson, Joseph S. Ross
Primary Institution: Mount Sinai School of Medicine
Hypothesis
Rates of non-adherence to FDA guidelines would be high and many advertisements would not present complete information important for safe prescribing.
Conclusion
Few physician-directed print pharmaceutical advertisements adhere to all FDA guidelines; over half fail to quantify serious risks.
Supporting Evidence
- 15 advertisements (18.1%) adhered to all FDA guidelines.
- 41 advertisements (49.4%) were non-adherent to at least one FDA mandated item.
- 57.8% of advertisements did not quantify serious risks.
- 48.2% lacked verifiable references.
- 28.9% failed to present adequate efficacy quantification.
Takeaway
This study looked at drug ads in medical journals and found that many don't follow the rules set by the FDA, which means doctors might not get the important safety information they need.
Methodology
Cross-sectional analysis of pharmaceutical advertisements in top U.S.-based biomedical journals from November 2008.
Potential Biases
Subjectivity in determining adherence to FDA guidelines may have led to underestimating non-adherence rates.
Limitations
The study focused on advertisements from a single month and the subjectivity of FDA guidelines.
Participant Demographics
Advertisements from 12 biomedical journals were analyzed.
Statistical Information
P-Value
p=0.06
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website